Head-to-head · Value Score
bmiMD vs Lyfe Rx
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Lyfe Rx a 66. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameLyfe Rx
#309 · Grade C · Watch List
Est. first month
From $225/mo (compounded)
Save ~83% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 66 — an est. $99/mo first month, with no teaser step-up baked in. Lyfe Rx isn't out of it: Shoppers who want use with caution — FDA warning letter on file.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Lyfe Rx |
|---|---|---|
| Value Score | 89 (A) | 66 (C) |
| Est. first month | $99/mo | From $225/mo (compounded) |
| Save vs brand-name | ~93% | ~83% |
| Semaglutide | $99/mo | From $225/mo (compounded) |
| Tirzepatide | $139/mo | From $299/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Lyfe Rx
Lyfe Rx offers compounded semaglutide ($289) and compounded tirzepatide ($399).
Why it's a deal
- Both compounded semaglutide and tirzepatide available
- Delivery to all 50 states with 1–3 day pharmacy turnaround
The fine print
- No visible LegitScript or PCAB accreditation
- Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
- Shopify-based e-commerce storefront — less clinical infrastructure
- FDA issued this company a warning letter dated 9 September 2025; the letter is public in FDA's warning-letter database
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Lyfe Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.